Limb Length Discrepancy

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Globus Medical
Globus MedicalAUDUBON, PA
2 programs
Intramedullary Limb Lengthening DeviceN/A1 trial
Precice IMLLN/A1 trial
Active Trials
NCT06714110Enrolling By Invitation200Est. Dec 2026
NCT06741514Enrolling By Invitation100Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Globus MedicalIntramedullary Limb Lengthening Device
Globus MedicalPrecice IMLL

Clinical Trials (2)

Total enrollment: 300 patients across 2 trials

NCT06714110Globus MedicalIntramedullary Limb Lengthening Device

A Review of Precice Intramedullary Limb Lengthening (IMLL) System for Limb Lengthening Procedures in Children.

Start: Mar 2025Est. completion: Dec 2026200 patients
N/AEnrolling By Invitation

A Study of Precice Intramedullary Limb Lengthening System (IMLL) Limb Lengthening Procedures

Start: Mar 2024Est. completion: Dec 2026100 patients
N/AEnrolling By Invitation

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space